[go: up one dir, main page]

FR3054441B1 - Utilisation de metabolites issues de la fermentation de lactobacillus afin de restaurer l'equilibre du microbiote cutane et intestinal - Google Patents

Utilisation de metabolites issues de la fermentation de lactobacillus afin de restaurer l'equilibre du microbiote cutane et intestinal Download PDF

Info

Publication number
FR3054441B1
FR3054441B1 FR1601163A FR1601163A FR3054441B1 FR 3054441 B1 FR3054441 B1 FR 3054441B1 FR 1601163 A FR1601163 A FR 1601163A FR 1601163 A FR1601163 A FR 1601163A FR 3054441 B1 FR3054441 B1 FR 3054441B1
Authority
FR
France
Prior art keywords
restore
balance
intestinal
microbiote
metabolites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1601163A
Other languages
English (en)
Other versions
FR3054441A1 (fr
Inventor
Bejit Ideas
Etienne Soudant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actina
Original Assignee
Actina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actina filed Critical Actina
Priority to FR1601163A priority Critical patent/FR3054441B1/fr
Publication of FR3054441A1 publication Critical patent/FR3054441A1/fr
Application granted granted Critical
Publication of FR3054441B1 publication Critical patent/FR3054441B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Composition dermocosmétique destinée à être utilisée par voie topique pour restaurer l'équilibre des microbiotes cutané et intestinale caractérisée en ce qu'elle contient au moins 150 métabolites différents provenant de la fermentation lente d'un mélange de plusieurs plantes par une association de lactobactéries contenant au moins une souche de bactéries issue de la plante d'Olea europaea millénaire et particulièrement ses feuilles.
FR1601163A 2016-07-28 2016-07-28 Utilisation de metabolites issues de la fermentation de lactobacillus afin de restaurer l'equilibre du microbiote cutane et intestinal Active FR3054441B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1601163A FR3054441B1 (fr) 2016-07-28 2016-07-28 Utilisation de metabolites issues de la fermentation de lactobacillus afin de restaurer l'equilibre du microbiote cutane et intestinal

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1601163A FR3054441B1 (fr) 2016-07-28 2016-07-28 Utilisation de metabolites issues de la fermentation de lactobacillus afin de restaurer l'equilibre du microbiote cutane et intestinal
FR1601163 2016-07-28

Publications (2)

Publication Number Publication Date
FR3054441A1 FR3054441A1 (fr) 2018-02-02
FR3054441B1 true FR3054441B1 (fr) 2020-12-25

Family

ID=57583116

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1601163A Active FR3054441B1 (fr) 2016-07-28 2016-07-28 Utilisation de metabolites issues de la fermentation de lactobacillus afin de restaurer l'equilibre du microbiote cutane et intestinal

Country Status (1)

Country Link
FR (1) FR3054441B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3122178B1 (fr) * 2021-04-22 2023-10-27 Actina Composition de traitement des plantes contenant le microbiote provenant d’arbres millénaires de l’espèceOlea europaea L. pour son utilisation dans l’augmentation de bioactifs et de métabolites dans les plantes.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009201449B2 (en) * 2009-04-14 2014-05-29 Shodoshima Healthy Land Co., Ltd. Extracted olive oil and production method thereof
EP2462991A1 (fr) * 2010-12-13 2012-06-13 PQS Group B.V. Composition et utilisation d'un produit de feuille d'olivier fermentée pour le traitement des infections des ongles
GR1008378B (el) * 2011-10-14 2014-12-16 ΠΑΝΕΛΛΗΝΙΟΣ ΕΝΩΣΙΣ ΜΕΤΑΠΟΙΗΤΩΝ - ΤΥΠΟΠΟΙΗΤΩΝ - ΕΞΑΓΩΓΕΩΝ ΕΠΙΤΡΑΠΕΖΙΩΝ ΕΛΑΙΩΝ με δ.τ. "ΠΕΜΕΤΕ", Λειτουργικες επιτραπεζιες ελιες ζυμωμενες με γαλακτικα βακτηρια που διαθετουν προβιοτικες ιδιοτητες
WO2014088520A1 (fr) * 2012-12-03 2014-06-12 Eraslan Mustafa Utilisation de combinaisons d'extrait de fruit de figuier et d'extrait de feuille d'olivier associées à des extraits de thé vert et de pépins de raisin
JP2015034131A (ja) * 2013-08-07 2015-02-19 片倉チッカリン株式会社 イチジク発酵抽出物及びその製造方法、並びにイチジク発酵抽出物を配合する化粧料

Also Published As

Publication number Publication date
FR3054441A1 (fr) 2018-02-02

Similar Documents

Publication Publication Date Title
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
EA202091389A1 (ru) Композиция на основе пробиотиков и её применение
EP3638777A4 (fr) Compositions et procédés pour augmenter l'efficacité de cultures cellulaires utilisées pour la production d'aliments
ZA202001057B (en) Inhibiting ubiquitin specific peptidase 30
MX367204B (es) Métodos y composiciones de limpieza personal concentradas.
GB2551642A (en) Methods and compositions relating to microbial treatment and diagnosis of dis-orders
MA34909B1 (fr) Triterpénoïdes modifi2s en c-17 et c-3 presentant une activité inhibitrice de la maturation du vih
MX2022012536A (es) Composiciones que comprenden polisacaridos sulfatados.
MA49628B1 (fr) Processus pour la purification de l'acide hyaluronique
WO2018106108A8 (fr) Composition pharmaceutique topique contenant de la phénytoïne et un (co-)analgésique pour le traitement de la douleur chronique
EP3624581A4 (fr) Compositions et méthodes de génération d'allèles faibles dans des plantes
FR3054441B1 (fr) Utilisation de metabolites issues de la fermentation de lactobacillus afin de restaurer l'equilibre du microbiote cutane et intestinal
MX2022002646A (es) Formulacion de ruxolitinib para la reduccion de comezon en dermatitis atopica.
ECSP22092205A (es) Composición farmacéutica acuosa de levilimab y su uso
PE20210319A1 (es) Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas
FR3061013B1 (fr) Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique
DOP2021000069A (es) Derivados de 4 pirazin-2-ilmetil-morfolina y su uso como medicamento
EP3366292A4 (fr) Composition pour la prévention ou le traitement de l'obésité contenant de l'acide alpha-lipoïque et de la n-acétylcystéine en tant que substances actives
CL2019003801A1 (es) Nuevas formulaciones orales de belinostato.
MX2013009230A (es) Composicion farmaceutica de diosmina y hesperidina y su uso en dolor neuropatico.
AR108150A1 (es) Composición para el cuidado bucal
FR3065874B1 (fr) Composition cosmetique se presentant sous la forme d'un produit d'hygiene liquide et limpide a ph inferieur a 8
FR3026105B1 (fr) Composition contenant au moins un inhibiteur de certaines chimiokines, son procede d'obtention et son utilisation dermocosmetique ou pharmaceutique
WO2019078804A3 (fr) Procédé de production de crème de traitement et anti-éruptions
EA201691518A1 (ru) Композиции, содержащие продукты пчеловодства

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180202

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9